A comparative study between the lunar soil simulant (LSS) and PM2.5 was performed to discover their harm to human biological systems and explore the methods of prevention and treatment of dust poisoning for future lunar manned landings. The steps to the moon never stopped after the Apollo Project. Lessons from manned landings on the moon have shown that lunar dust has great influence on the health of astronauts.
All news from Anaesthesiology
Novel vaccine technologies are critical to improving the public health response to infectious disease threats that continually emerge and re-emerge, according to scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
In a perspective in The Journal of the American Medical Association, the experts highlight innovations that could significantly shorten the typical decades-long vaccine development timeline.
Researchers at NYU School of Medicine and NYU College of Dentistry reported that gut bacteria suppress the immune system which in turn promotes pancreatic cancer. The findings, published in the journal Cancer Discovery, suggests that targeting the microbiome may make immunotherapy effective against pancreatic cancer.
According to research from the American Heart Association's Epidemiology and Prevention / Lifestyle and Cardiometabolic Health Scientific Sessions 2018, a premier global exchange of the latest advances in population-based cardiovascular science for researchers and clinicians. Losing two or more teeth in middle age is associated with increased cardiovascular disease risk.
The burden of yellow fever in any given area is known to be heavily dependent on climate, particularly rainfall and temperature which can impact both mosquito life cycle and viral replication.
Now, researchers from Imperial College London and the WHO have developed a new model to quantify yellow fever dynamics across Africa using not only annual averages of these climatic measures, but seasonal dynamics. Their work is described in PLOS Neglected Tropical Diseases.
Using computer modeling, researchers from Houston Methodist have found that edelfosine, an FDA-approved investigational leukemia drug, can prevent cancer cells from metastasizing. The study findings were published in the journal Cancer Research.
Researchers have shown a key protein called KMT2D involved in the epigenetic regulation of gene expression guides this renewal. Epigenetics involves chemical modifications to DNA and its supporting proteins that affect the availability of genes to be "read" and made into proteins. The study was published in Genes & Development.
Researchers at National Jewish Health have identified 10 immune-related genes whose activity during a respiratory infection predict the long-term prognosis for cystic fibrosis patients better than conventional measures.
Five years after being evaluated, patients in the lowest-risk group were all alive and doing well, whereas 90% of patients in the highest risk cluster had been admitted to an intensive care unit, put on mechanical ventilation, referred for lung transplant, had a transplant or died. National Jewish Health has applied for a patent on the 10-gene panel.
Low back pain is the leading cause of disability worldwide, affecting an estimated 540 million people. Many of the patients being treated for back pain receive the wrong treatment, making the condition worse instead of curing it, according to a study published in the journal The Lancet.
A study examines that pregnant women with polycystic ovary syndrome previously treated with the antiandrogenic therapy ethinylestradiol/cyproterone acetate have a lower risk for gestational diabetes and pregnancy-induced hypertension compared with healthy pregnant women and pregnant women with PCOS who did not receive the treatment.
Researchers at Memorial Sloan Kettering Cancer Center in New York City and Massachusetts Institute of Technology in Boston have developed a new, three-step system that uses nuclear medicine to target and eliminate colorectal cancer.
In this study with a mouse model, researchers achieved a 100% cure rate — without any treatment-related toxic effects. The study is reported in the November featured article in The Journal of Nuclear Medicine.